Healthcare -
Biotechnology - NASDAQ - US
$ 0.4974
-5.06 %
$ 29.4 M
Market Cap
-0.62
P/E
ELEV - STOCK-BASED COMPENSATION
Stock-based Compensation ELEV - Elevation Oncology, Inc.
3.34 M
LAST VALUE
45.70%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR